Device
Magnetoencephalograph (MEG)
Magnetoencephalograph (MEG) is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
unknown
Changes in Brain Synchronization During Perceptual and Linguistic Tasks in Schizophrenic Patients
NCT01550211
completednot_applicable
Magnetoencephalographic (MEG) Evidence for Novel Metaphor Processing Among Schizophrenic Patients
NCT01325363
unknownnot_applicable
Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia
NCT01382433
Clinical Trials (3)
Showing 3 of 3 trials
NCT01550211
Changes in Brain Synchronization During Perceptual and Linguistic Tasks in Schizophrenic Patients
NCT01325363Not Applicable
Magnetoencephalographic (MEG) Evidence for Novel Metaphor Processing Among Schizophrenic Patients
NCT01382433Not Applicable
Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3